logo
  

Schneider Electric Confirms Talks With Bentley Systems On Potential Deal; Stock Down

Schneider Electric SA (SBGSF.PK), a French digital automation and energy management firm, on Friday confirmed that it has been engaged in preliminary talks on a potential deal with Bentley Systems Inc. (BSY), an American software company.

In response to recent press articles, the company said, "Discussions remain at a preliminary stage regarding a potential transaction, and there is no certainty that any transaction will be agreed upon. No further comment will be made until an update is warranted."

Earlier, the Wall Street Journal reported, citing people familiar with the matter, that Schneider Electric is in talks to take control of Bentley Systems in a deal that could be worth more than $15 billion.

As per the report, Schneider would merge its software business with Bentley, which would remain a public company.

Schneider now said the move serves as part of its continuous exploration of opportunities in furtherance of its One Software strategy.

In Paris, Schneider Electric shares were losing around 2.4 percent, to trade at 210.25 euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission announced that it has opened formal proceedings against Meta Platforms to assess whether the owner of Facebook and Instagram may have breached the Digital Services Act or DSA in areas linked to the protection of minors. On the Nasdaq Stock Exchange, Meta shares were losing around 1.1 percent. Retail giant Walmart reported Thursday a profit for the first quarter that soared from last year, reflecting higher gross margins and strong growth across all its operating segments. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. While reporting financial results for the first quarter on Thursday, retail giant Walmart, Inc. (WMT) initiated its adjusted earnings and net sales growth guidance for the second quarter, well above analysts' estimates. It also maintained full-year 2025 outlook. For the second quarter, the company...

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
Follow RTT